To address this knowledge gap, our study aimed to assess serum levels of key pro-inflammatory cytokines—specifically interleukin one beta (IL-1β), interleukin 6 (IL-6), and tumor necrosis factor-alpha (TNF-α) in KC patients compared to healthy controls. This evidence concerns the gene IL6 and keratoconus.